Loading clinical trials...
Loading clinical trials...
Research questions: The value of primary prevention implantable cardioverter-defibrillator implantation (ICD) therapy in patients with non-ischemic cardiomyopathy (NICM) is under debate. Improved risk...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
University Medical Center Groningen
Collaborators
NCT06856993 · Sudden Cardiac Death, Exosome Multiomics, and more
NCT05373940 · Heart Failure, Primary Prevention of Sudden Cardiac Death, and more
NCT07028372 · Cardiac Arrest (CA), Resuscitated Sudden Cardiac Death, and more
NCT07444931 · Coronary Arterial Disease (CAD), Sudden Cardiac Arrest, and more
NCT07438938 · Cardiac Arrest (CA), Out-of-hospital Cardiac Arrest (OHCA), and more
University Medical Center Groningen
Groningen
Radboud University Medical Center
Nijmegen
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions